LEADER 01266nam  2200385   450 
001 9910159436003321
005 20230810001748.0
010   $a1-5361-0521-X
035   $a(CKB)3710000001019036
035   $a(MiAaPQ)EBC4789250
035   $a(EXLCZ)993710000001019036
100   $a20170206h20172017  uy|            0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aAdvances in studies on enzyme inhibitors as drugs$hVolume 2$iMiscellaneous drugs /$fSatya P. Gupta, editor
210  1$aNew York :$cNova Biomedical,$d[2017]
210  4$dİ2017
215   $a1 online resource (341 pages) $cillustrations (some color)
225 1 $aPharmacology - research, safety testing and regulation,$x2474-9524
311   $a1-5361-0505-8 
320   $aIncludes bibliographical references and index.
410  0$aPharmacology-research, safety testing, and regulation series.
606   $aEnzyme inhibitors
615  0$aEnzyme inhibitors.
702   $aGupta$b Satya Prakash
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910159436003321
996   $aAdvances in studies on enzyme inhibitors as drugs$93417451
997   $aUNINA